IGC Pharma (IGC) Receivables - Other (2011 - 2026)
IGC Pharma's Receivables - Other was $657,000 in Q4 2026, down 3.4% from $680,000 a year earlier and down 1.5% from the prior quarter.
Powered by 
Analysis
IGC Pharma (IGC) Receivables - Other (2011 - 2026) Analysis & Trends
From Q3 2012 onward, IGC Pharma has reported Receivables - Other for 41 quarters.
- Receivables - Other has now declined for three consecutive years, though with a five-year compound annual growth rate of 11.5% (FY2021 to FY2026).
- In earlier years, Receivables - Other was $680,000 in FY2025 (-0.9%), $686,000 in FY2024 (-27.9%), $951,000 in FY2023 (+158.4%) and $368,000 in FY2022 (-3.7%).
- The Q4 2026 figure marks the lowest quarterly Receivables - Other since Q1 2023.
- Compared with a year earlier, Receivables - Other has declined for nine straight quarters, with an average decline of 11.6% over the last eight quarters.
- The best year-over-year quarter for Receivables - Other over five years was Q1 2024 (growth of 168.6%); the worst was Q3 2025 (a decline of 28.2%).
- Per Business Quant data, IGC's Receivables - Other in the three quarters before Q4 2026 was $667,000 (Q3 2026), $670,000 (Q2 2026) and $680,000 (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | IGC Pharma | 26.67 Mn | 23.92 Mn | 55,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 657,000.00 |
| Dec 31, 2025 | 667,000.00 |
| Sep 30, 2025 | 670,000.00 |
| Jun 30, 2025 | 680,000.00 |
| Mar 31, 2025 | 680,000.00 |
| Dec 31, 2024 | 679,000.00 |
| Sep 30, 2024 | 685,000.00 |
| Jun 30, 2024 | 686,000.00 |
| Mar 31, 2024 | 686,000.00 |
| Dec 31, 2023 | 946,000.00 |
| Sep 30, 2023 | 947,000.00 |
| Jun 30, 2023 | 951,000.00 |
| Mar 31, 2023 | 951,000.00 |
| Dec 31, 2022 | 751,000.00 |
| Sep 30, 2022 | 751,000.00 |
| Jun 30, 2022 | 354,000.00 |
| Mar 31, 2022 | 368,000.00 |
| Dec 31, 2021 | 382,000.00 |
| Sep 30, 2021 | 376,000.00 |
| Jun 30, 2021 | 375,000.00 |
API Access
IGC Pharma Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=IGC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "IGC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=IGC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();